Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Accured Expenses (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Change in Accured Expenses for 7 consecutive years, with -$4.8 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 311.04% to -$4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, down 3.4% year-over-year, with the annual reading at $10.4 million for FY2025, 3.4% down from the prior year.
  • Change in Accured Expenses hit -$4.8 million in Q4 2025 for IDEAYA Biosciences, down from $7.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $7.5 million in Q3 2025 to a low of -$4.8 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $1.6 million across 5 years, with a median of $2.1 million in 2021.
  • Biggest YoY gain for Change in Accured Expenses was 668.11% in 2023; the steepest drop was 399.29% in 2023.
  • Year by year, Change in Accured Expenses stood at $476000.0 in 2021, then crashed by 32.14% to $323000.0 in 2022, then skyrocketed by 668.11% to $2.5 million in 2023, then decreased by 8.34% to $2.3 million in 2024, then plummeted by 311.04% to -$4.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for IDYA at -$4.8 million in Q4 2025, $7.5 million in Q3 2025, and $4.8 million in Q2 2025.